Cargando…
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix
The tumor-suppressor protein p16 is paradoxically overexpressed in cervical cancer (CC). Despite its potential as a biomarker, its clinical value and the reasons for its failure in tumor suppression remain unclear. Our purpose was to determine p16 clinical and biological significance in CC. p16 expr...
Autores principales: | Mendaza, Saioa, Fernández-Irigoyen, Joaquín, Santamaría, Enrique, Zudaire, Tamara, Guarch, Rosa, Guerrero-Setas, David, Vidal, August, Santos-Salas, José, Matias-Guiu, Xavier, Ausín, Karina, Díaz de Cerio, María José, Martín-Sánchez, Esperanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139571/ https://www.ncbi.nlm.nih.gov/pubmed/32204550 http://dx.doi.org/10.3390/ijms21062125 |
Ejemplares similares
-
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix
por: Mendaza, Saioa, et al.
Publicado: (2021) -
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis
por: Mendaza, Saioa, et al.
Publicado: (2021) -
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017) -
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
por: Mendaza, Saioa, et al.
Publicado: (2020) -
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease
por: Ferrer, Isidro, et al.
Publicado: (2021)